MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

ABIOMED Company Profile (NASDAQ:ABMD)

Consensus Ratings for ABIOMED (NASDAQ:ABMD) (?)
Ratings Breakdown: 2 Hold Rating(s), 8 Buy Rating(s)
Consensus Rating:Buy (Score: 2.80)
Consensus Price Target: $113.11 (13.41% upside)

Analysts' Ratings History for ABIOMED (NASDAQ:ABMD)
Show:
DateFirmActionRatingPrice TargetActions
5/5/2016Leerink SwannReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/9/2016Jefferies GroupReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/10/2016Benchmark Co.Reiterated RatingBuy$145.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/5/2016Piper JaffrayReiterated RatingHold$75.00 -> $90.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/5/2016BTIG ResearchReiterated RatingBuy$110.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/30/2015Raymond JamesUpgradeMarket Perform -> Outperform$85.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/29/2015Sterne Agee CRTReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/17/2015CRT CapitalInitiated CoverageBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/14/2015StephensReiterated RatingOverweight$103.00 -> $128.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/5/2015Northland SecuritiesBoost Price TargetMarket Perform$60.00 -> $80.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/28/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha